Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Toby M. Maher(Royal Brompton Hospital), Tamera J. Corte(Royal Prince Alfred Hospital), Aryeh Fischer(Bristol-Myers Squibb (United States)), Michael Kreuter(Heidelberg University), David J. Lederer(Columbia University Irving Medical Center), María Molina‐Molina(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Judit Axmann(Roche (Switzerland)), Klaus-Uwe Kirchgaessler(Roche (Switzerland)), Katerina Samara(Roche (Greece)), Frank Gilberg(Roche (Switzerland)), Vincent Cottin(Hôpital Louis Pradel)
Cited by 625
Abstract
Related Papers
No related papers found
Powered by citation graph analysis